Bullfrog AI Holdings, Inc. (BFRGW)
| Market Cap | 9.87M -41.8% |
| Revenue (ttm) | 298,798 |
| Net Income | -6.00M |
| EPS | -0.45 |
| Shares Out | 18.54M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | 0.1300 |
| Day's Range | n/a |
| 52-Week Range | 0.0751 - 0.6488 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About BFRGW
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebend... [Read more]
News
BullFrog AI to Present at the 20th Annual LD Micro Main Event on October 20, 2026
GAITHERSBURG, Md., Oct. 13, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), an AI company using its proprietary platform to turn complex bio...
Bullfrog AI provides update on commercial program with pharmaceutical company
BullFrog AI (BFRG) announced it has achieved project milestones under its commercial program with a global pharmaceutical company. BullFrog AI successfully identified and prioritized novel therapeutic...
BullFrog AI Announces Positive Progress in Drug Discovery Program for Top 5 Global Pharmaceutical in Major Depressive Disorder
Achieves key commercial project milestones utilizing its proprietary artificial intelligence (“AI”) and machine learning platform to identify and prioritize therapeutic targets Achieves key commercial...
Bullfrog AI Holdings Slides: Corporate presentation
Bullfrog AI Holdings has posted slides in relation to its latest quarterly earnings report, which was published on September 15, 2026.
BullFrog AI to Participate in September 2026 Investor Conferences
GAITHERSBURG, Md., Sept. 08, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), an AI company using three complementary capabilities to turn co...
Bullfrog AI Holdings Quarterly report: Q2 2026
Bullfrog AI Holdings has published its Q2 2026 quarterly earnings report on August 14, 2026.
BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference
GAITHERSBURG, Md., July 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), an AI company using three complementary capabilities to turn com...
BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026
GAITHERSBURG, Md., July 21, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), an AI company using three complementary capabilities to turn com...
Water Tower Research Publishes Initiation of Coverage Report on BullFrog AI Holdings, Inc., "Helping Big Pharma Look Before It Leaps in Drug Discovery"
June 24, 2026, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on BullFrog AI Holdings, Inc. (NASDAQ: BFRG) titled, “Helping Big P...
BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform
GAITHERSBURG, Md., June 02, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and ma...
Bullfrog AI registers to sell 2M shares of common stock for holders
This filing relates to the offer and sale from time to time by the selling stockholder of up to 2M shares of common stock. The company is not selling any…
Bullfrog AI Holdings Registration statement: Registration filing
Bullfrog AI Holdings filed a registration statement on May 29, 2026, providing details about a securities offering with the SEC.
Bullfrog AI Holdings Quarterly report: Q1 2026
Bullfrog AI Holdings has published its Q1 2026 quarterly earnings report on May 14, 2026.
Bullfrog AI Holdings Proxy statement: Proxy filing
Bullfrog AI Holdings filed a proxy statement on May 1, 2026, providing details for shareholder voting and corporate governance matters.
Bullfrog AI Holdings Proxy statement: Proxy filing
Bullfrog AI Holdings filed a proxy statement on April 30, 2026, providing details for shareholder voting and corporate governance matters.
Bullfrog AI regains compliance with Nasdaq
BullFrog AI (BFRG) announced that it has received a written notice from Nasdaq stating that the company has regained compliance with the minimum stockholders’ equity requirement under Nasdaq Listing R...
BullFrog AI Regains Compliance with Nasdaq Shareholders' Equity Requirement
GAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and m...
BullFrog AI Announces Participation at AACR Annual Meeting
BullFrog AI team will be available to discuss its end-to-end drug discovery and development workflow at booth 2957 BullFrog AI team will be available to discuss its end-to-end drug discovery and devel...
BullFrog AI issues shareholder letter highlighting recent progress, outlook
BullFrog AI (BFRG) issued a letter to shareholders from founder and CEO Vin Singh stating the company has secured the financial runway to execute its strategy into late 2027 and…
BullFrog AI issues shareholder letter highlighting recent progress, outlook
BullFrog AI (BFRG) issued a letter to shareholders from founder and CEO Vin Singh stating the company has secured the financial runway to execute its strategy into late 2027 and…
BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners
GAITHERSBURG, Md., April 13, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (Nasdaq: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence and machine ...
Bullfrog AI stock offers a rare opportunity for investors to take profit
Bullfrog AI Inc more than doubled on Mar. 30 after announcing a landmark commercial agreement with a “top 5” pharma leader to identify novel therapeutic targets for Major Depressive Disorder. In its p...
Bullfrog AI enters commercial agreement with pharmaceutical company
BullFrog AI (BFRG) announced a commercial agreement with a global pharmaceutical company to apply the company’s proprietary bfLEAP platform to identify and prioritize novel drug targets in major depre...
BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder
GAITHERSBURG, Md., March 30, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology company using artificial intelligence (“AI”) and m...
BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine
Completes end-to-end AI intelligence workflow product with an advanced AI decision tool that clearly defines drug target discovery and clinical trial strategies to build diversified, risk-balanced R&D...